Neuroblastoma is a childhood cancer, most commonly affecting children aged between two to three and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's ...
May 7, 2021
0
108
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study ...
Apr 2, 2021
0
38
Preclinical research from VCU Massey Cancer Center published recently in the Proceedings of the National Academy of Sciences shows that the combination of two existing drugs can exploit the metabolic 'hunger' of a particularly ...
Mar 30, 2021
0
71
Australian researchers have discovered a new way to target an aggressive childhood cancer, neuroblastoma, one of the most common and dangerous cancers in young children.
Mar 26, 2021
0
433
A factor that turns malignant tumors into benign ones? That is exactly what scientists at St. Anna Children's Cancer Research Institute have discovered. Together with colleagues from the Medical University of Vienna and the ...
Mar 12, 2021
0
128
A new study by Mayo Clinic researchers has identified that a chromosome instability gene, USP24, is frequently missing in pediatric patients with neuroblastoma, an aggressive form of childhood cancer. The finding provides ...
Feb 17, 2021
0
4
The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital ...
Feb 5, 2021
0
46
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs. In a new study in the journal Cancer Research, they describe ...
Jan 7, 2021
0
12
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumor aggressiveness and low survival ...
Dec 11, 2020
0
4
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumors, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer.
Nov 25, 2020
0
33
